Robert Langreth

The announcement by Moderna Inc. and Merck & Co. that a messenger RNA-based cancer vaccine had lowered the recurrence rate for melanoma in a final-stage trial is a watershed moment for cancer vaccine research. It’s the first time that an mRNA-based cancer vaccine has succeeded in a large-scale study. While the companies didn’t disclose details about the results, the success has bolstered hopes that mRNA-based shots could someday play a broad role in fighting one of the world’s leading causes

Revolution Medicines Inc. secured US regulatory approval for its pancreatic cancer drug daraxonrasib, the first medicine to target one of the key molecular causes of the disease.

Revolution Medicines Inc. secured U.S. regulatory approval for its pancreatic cancer drug daraxonrasib, the first medicine to target one of the key molecular causes of the disease.

Since last year, pharma companies have announced 24 final-stage trials for medicines targeting the disease.

Revolution Medicines Inc. secured US regulatory approval for its pancreatic cancer drug daraxonrasib, the first medicine to target one of the key molecular causes of the disease.

Revolution Medicines Inc. won U.S. approval for a breakthrough pill that lengthens the lives of patients with advanced pancreatic cancer, a major advance against one of the hardest-to-treat tumor types.

The Boeing Co. 767 cargo jet that crashed at Miami International Airport overran the runway, and plowed through two vehicles before stopping roughly a quarter-mile past the paved surface, the National Transportation Safety Board said in its first detailed federal account of Sunday’s fatal accident.

National By Robert Langreth, Bloomberg News The Tribune Content Agency September 7, 2026 3:57 PM

The Boeing Co. 767 cargo jet that crashed at Miami International Airport overran the runway, and plowed through two vehicles before stopping roughly

Bloomberg journalists answer your questions about the future of cancer treatment in a Live Q&A on Friday, Sept. 11 at 11 a.m. EDT